Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Collegium Pharmaceutical awarded 50,305 restricted stock units to 34 newly hired non-executive employees. The grants were issued under the company's 2026 Inducement Plan as a material inducement to employment, complying with Nasdaq Listing Rule 5635(c)(4).
Key figures
- New hires
- 34
- Rsus granted
- 50305
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.